Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2013

Sep 5, 2013

30870_dirs_2013-09-05_2eb91e47-f108-4e0a-89e9-0081ee491f52.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-09-03

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-03 Common Stock M 29166 Acquired 32235 Direct
2013-09-03 Common Stock D 10959 $7.65 Disposed 21276 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-09-03 Restricted Stock Units $ M 29166 Disposed Common Stock (29166) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2083 Indirect
Common Stock 2083 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of CYTK common stock at a purchase price of $0.001 per share which is the current par value of the common stock.

F2: Shares withheld by Issuer to cover taxes associated with settlement of Restricted Stock Units

F3: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F4: Shares held by The Brittany Blum 2003 Irrevocable Trust.

F5: The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013.